<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(3)</volume><submitter>Garza-Gonzalez E</submitter><pubmed_abstract>AIM:We aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens of epidemiological importance in 47 Mexican centers. MATERIAL AND METHODS:In this retrospective study, we included a stratified sample of 47 centers, covering 20 Mexican states. Selected isolates considered as potential causatives of disease collected over a 6-month period were included. Laboratories employed their usual methods to perform microbiological studies. The results were deposited into a database and analyzed with the WHONET 5.6 software. RESULTS:In this 6-month study, a total of 22,943 strains were included. Regarding Gram-negatives, carbapenem resistance was detected in ≤ 3% in Escherichia coli, 12.5% in Klebsiella sp. and Enterobacter sp., and up to 40% in Pseudomonas aeruginosa; in </pubmed_abstract><journal>PloS one</journal><pagination>e0209865</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6435111</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period.</pubmed_title><pmcid>PMC6435111</pmcid><pubmed_authors>Flores-Trevino S</pubmed_authors><pubmed_authors>Martinez-Ramirez A</pubmed_authors><pubmed_authors>Moreno-Mendez MI</pubmed_authors><pubmed_authors>Aviles-Benitez LK</pubmed_authors><pubmed_authors>Canizales-Oviedo J</pubmed_authors><pubmed_authors>Mena-Ramirez JP</pubmed_authors><pubmed_authors>Couoh-May CA</pubmed_authors><pubmed_authors>Arroyo-Escalante S</pubmed_authors><pubmed_authors>Lopez-Ovilla I</pubmed_authors><pubmed_authors>Sanchez-Francia D</pubmed_authors><pubmed_authors>Rosales-Garcia AA</pubmed_authors><pubmed_authors>Cetina-Umana CM</pubmed_authors><pubmed_authors>Bocanegra-Ibarias P</pubmed_authors><pubmed_authors>Rodriguez-Noriega E</pubmed_authors><pubmed_authors>Rojas-Larios F</pubmed_authors><pubmed_authors>Morales-De-la-Pena CT</pubmed_authors><pubmed_authors>Camacho-Ortiz A</pubmed_authors><pubmed_authors>Feliciano-Guzman JM</pubmed_authors><pubmed_authors>Juarez-Velazquez GE</pubmed_authors><pubmed_authors>Jaime-Sanchez JL</pubmed_authors><pubmed_authors>Navarro-Rodriguez A</pubmed_authors><pubmed_authors>Ayala-Tarin MD</pubmed_authors><pubmed_authors>Rivera-Garay R</pubmed_authors><pubmed_authors>Garza-Gonzalez E</pubmed_authors><pubmed_authors>Cobos-Canul DI</pubmed_authors><pubmed_authors>Silva-Sanchez J</pubmed_authors><pubmed_authors>Mora JP</pubmed_authors><pubmed_authors>Franco-Cendejas R</pubmed_authors><pubmed_authors>Galindo-Espinoza A</pubmed_authors><pubmed_authors>Martinez-Miranda R</pubmed_authors><pubmed_authors>Quintanilla LJ</pubmed_authors><pubmed_authors>Arevalo-Mejia A</pubmed_authors><pubmed_authors>Romero-Romero D</pubmed_authors><pubmed_authors>Maldonado-Anicacio JY</pubmed_authors><pubmed_authors>Aguirre-Burciaga E</pubmed_authors><pubmed_authors>Molina-Jaimes A</pubmed_authors><pubmed_authors>Barajas-Magallon JM</pubmed_authors><pubmed_authors>Ostos-Cantu HL</pubmed_authors><pubmed_authors>Aguilar-Orozco G</pubmed_authors><pubmed_authors>Vazquez-Narvaez EG</pubmed_authors><pubmed_authors>Morfin-Otero R</pubmed_authors><pubmed_authors>Monroy-Colin VA</pubmed_authors><pubmed_authors>Sida-Rodriguez S</pubmed_authors><pubmed_authors>Velazquez-Acosta C</pubmed_authors><pubmed_authors>Perez-Vega BA</pubmed_authors><pubmed_authors>Corte-Rojas RE</pubmed_authors><pubmed_authors>Gomez-Choel A</pubmed_authors><pubmed_authors>Ponce-de-Leon A</pubmed_authors><pubmed_authors>Rincon-Zuno J</pubmed_authors><pubmed_authors>Mendoza-Olazaran S</pubmed_authors><pubmed_authors>Coronado-Ramirez M</pubmed_authors><pubmed_authors>Pena-Lopez CD</pubmed_authors></additional><is_claimable>false</is_claimable><name>A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period.</name><description>AIM:We aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens of epidemiological importance in 47 Mexican centers. MATERIAL AND METHODS:In this retrospective study, we included a stratified sample of 47 centers, covering 20 Mexican states. Selected isolates considered as potential causatives of disease collected over a 6-month period were included. Laboratories employed their usual methods to perform microbiological studies. The results were deposited into a database and analyzed with the WHONET 5.6 software. RESULTS:In this 6-month study, a total of 22,943 strains were included. Regarding Gram-negatives, carbapenem resistance was detected in ≤ 3% in Escherichia coli, 12.5% in Klebsiella sp. and Enterobacter sp., and up to 40% in Pseudomonas aeruginosa; in </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-06-01T02:54:31.805Z</modification><creation>2025-06-01T02:54:31.805Z</creation></dates><accession>S-EPMC6435111</accession><cross_references><pubmed>30913243</pubmed><doi>10.1371/journal.pone.0209865</doi></cross_references></HashMap>